GRCE

Grace Therapeutics
GRCE

Overview Fund Trends Analyst Outlook Journalist POV

15 hedge funds and large institutions have $7.84M invested in Grace Therapeutics in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$857K
2
+$100K
3
+$90.2K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$11

Top Sellers

1
-$695K
2
-$451K
3
-$4.62K
4
UBS Group
UBS Group
Switzerland
-$84
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.89M
2
$1.96M
3
$1.85M
4
$857K
5
$161K
6
$90.2K
7
$10.2K
8
$7.04K
9
$5.6K
10
$2K
11
$389
12
$116
13
$105
14
$65
15
$4
16
–